Carregant...

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Prostate cancer is the second most common cancer in men worldwide and causes over 250,000 deaths each year(1). Overtreatment of indolent disease also results in significant morbidity(2). Common genetic alterations in prostate cancer include losses of NKX3.1 (8p21)(3,4) and PTEN (10q23)(5,6), gains o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Barbieri, Christopher E., Baca, Sylvan C., Lawrence, Michael S., Demichelis, Francesca, Blattner, Mirjam, Theurillat, Jean-Philippe, White, Thomas A., Stojanov, Petar, Van Allen, Eliezer, Stransky, Nicolas, Nickerson, Elizabeth, Chae, Sung-Suk, Boysen, Gunther, Auclair, Daniel, Onofrio, Robert, Park, Kyung, Kitabayashi, Naoki, MacDonald, Theresa Y., Sheikh, Karen, Vuong, Terry, Guiducci, Candace, Cibulskis, Kristian, Sivachenko, Andrey, Carter, Scott L., Saksena, Gordon, Voet, Douglas, Hussain, Wasay M., Ramos, Alex H., Winckler, Wendy, Redman, Michelle C., Ardlie, Kristin, Tewari, Ashutosh K., Mosquera, Juan Miguel, Rupp, Niels, Wild, Peter J., Moch, Holger, Morrissey, Colm, Nelson, Peter S., Kantoff, Philip W., Gabriel, Stacey B., Golub, Todd R., Meyerson, Matthew, Lander, Eric S., Getz, Gad, Rubin, Mark A., Garraway, Levi A.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3673022/
https://ncbi.nlm.nih.gov/pubmed/22610119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ng.2279
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!